StonvexLoading…
StonvexStonvexStonvexCore line items from CLMB's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2024 2024-03-31 | Annual 2023 2023-12-31 | Q3 2023 2023-09-30 | Q2 2023 2023-06-30 |
|---|---|---|---|---|
Revenue | $92.42M | $352.01M | $245.23M | $166.77M |
Operating Income | $3.50M | $16.49M | $9.04M | $5.75M |
Net Income | $2.73M | $12.32M | $7.08M | $1.38M |
EPS (Diluted) | $0.60 | $2.72 | $1.57 | $1.05 |
Total Assets | $298.32M | $335.10M | $232.37M | $233.70M |
Total Liabilities | $221.87M | $260.33M | $164.74M | $166.72M |
Cash & Equivalents | $43.57M | $36.30M | $49.78M | $43.87M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 4.59M | 4.57M | 4.58M | 4.57M |